Endometrial Serous Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Serous Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma [Phase 3]
A Phase 3 clinical trial is evaluating the addition of Herceptin Hylecta or Phesgo to standard chemotherapy for HER2-positive endometrial se…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy [EARLY_Phase 1]
An early-phase clinical trial sponsored by the National Cancer Institute is evaluating the anti-cancer drug Triapine in endometrial serous c…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma [Phase 2]
Phase 2 study evaluating the combination of niraparib and dostarlimab for recurrent or persistent endometrial serous carcinoma. The trial is…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the Wee1 inhibitor adavosertib (AZD1775) in women with recurrent or persiste…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
MD Anderson Cancer Center is conducting a study to determine if liquid biopsies and tumor molecular profiling can predict recurrence in vari…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS withdrawal · 2024-12-19Clinical Trial Update: Niraparib in High-grade Endometrial Cancer Trial [EARLY_Phase 1]
A Phase 1 Niraparib trial for high-grade endometrial cancer has been withdrawn.